Literature DB >> 10023420

Factors in fibroid growth.

J Andersen1.   

Abstract

Uterine leiomyomas, commonly called fibroids, are benign tumours of myometrial origin. The tumours enlarge in as many as 30% of women over 30 years of age, causing significant morbidity. Recent research has been directed towards understanding the factors involved in their enlargement. The ovarian steroid hormones oestrogen and progesterone contribute to the pathology of leiomyomas but in unexpected ways. During the follicular phase, oestrogen maintains the high expression of several genes that are normally expressed in the expanding myometrium of pregnancy; however, increased mitotic activity is not induced. During the luteal phase, increased mitotic activity is observed in leiomyomas, particularly in younger women. Progesterone increases the mitotic rate of the tumours in vitro and may induce the production of growth factors and/or their respective receptors during the luteal phase. In addition, a number of non-random chromosomal translocations have been observed in developing clonal tumours. This review will survey factors that may promote enlargement of uterine leiomyomas.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10023420

Source DB:  PubMed          Journal:  Baillieres Clin Obstet Gynaecol        ISSN: 0950-3552


  10 in total

1.  History of uterine leiomyoma and risk of endometrial cancer in black women.

Authors:  Lauren A Wise; Todd R Sponholtz; Lynn Rosenberg; Lucile L Adams-Campbell; Wendy Kuohung; Michael P LaValley; Julie R Palmer
Journal:  Cancer Causes Control       Date:  2016-02-29       Impact factor: 2.506

Review 2.  The expression and potential regulatory function of microRNAs in the pathogenesis of leiomyoma.

Authors:  Xiaoping Luo; Nasser Chegini
Journal:  Semin Reprod Med       Date:  2008-10-24       Impact factor: 1.303

3.  Association of exposure to phthalates with endometriosis and uterine leiomyomata: findings from NHANES, 1999-2004.

Authors:  Jennifer Weuve; Russ Hauser; Antonia M Calafat; Stacey A Missmer; Lauren A Wise
Journal:  Environ Health Perspect       Date:  2010-02-25       Impact factor: 9.031

4.  Prospective study of dietary fat and risk of uterine leiomyomata.

Authors:  Lauren A Wise; Rose G Radin; Shiriki K Kumanyika; Edward A Ruiz-Narváez; Julie R Palmer; Lynn Rosenberg
Journal:  Am J Clin Nutr       Date:  2014-03-05       Impact factor: 7.045

5.  Association of intrauterine and early life factors with uterine leiomyomata in black women.

Authors:  Lauren A Wise; Rose G Radin; Julie R Palmer; Lynn Rosenberg
Journal:  Ann Epidemiol       Date:  2012-10-23       Impact factor: 3.797

6.  An unusual karyotype in leiomyoma: Case report and literature review.

Authors:  Le Chang; Nagesh Rao; Nicholas Bernthal; Sarah M Dry; Aaron W James
Journal:  J Orthop       Date:  2015-11-02

7.  Mifepristone 2.5 mg versus 5 mg daily in the treatment of leiomyoma before surgery.

Authors:  Josep L Carbonell Esteve; Ana M Riverón; Mariela Cano; Alma I Ortiz; Aleta Valle; Carlos S Texidó; Giuseppe Tomasi
Journal:  Int J Womens Health       Date:  2012-03-13

Review 8.  Uterine Fibroids and Progestogen Treatment: Lack of Evidence of Its Efficacy: A Review.

Authors:  Jacques Donnez
Journal:  J Clin Med       Date:  2020-12-05       Impact factor: 4.241

Review 9.  Etiology and pathogenesis of uterine leiomyomas: a review.

Authors:  Gordon P Flake; Janet Andersen; Darlene Dixon
Journal:  Environ Health Perspect       Date:  2003-06       Impact factor: 9.031

10.  Abnormal uterine bleeding as a presenting symptom is related to multiple uterine leiomyoma: an ultrasound-based study.

Authors:  José Alberto Fonseca-Moutinho; Lígia Silva Barbosa; Daniel Gonçalves Torres; Sara Morgado Nunes
Journal:  Int J Womens Health       Date:  2013-10-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.